Neurogene (NGNE) Current Leases (2018 - 2026)
Neurogene (NGNE) posted Current Leases of $9000.0 for Q1 2026, down 35.71% on a QoQ basis from $14000.0 in Q4 2025, and down 81.25% year-over-year from $48000.0 in Q1 2025.
Neurogene (NGNE) Current Leases (2018 - 2026) Analysis & Trends
Neurogene's Current Leases history runs 9 years deep, the most recent figure standing at $9000.0 for Q1 2026.
- Quarterly Current Leases fell 81.25% year-over-year to $9000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9000.0 (down 81.25% YoY) and the FY2025 annual result came in at $14000.0, down 74.07% from the prior year.
- Current Leases was $9000.0 for Q1 2026 at Neurogene, down from $14000.0 in the prior quarter.
- Across five years, Current Leases topped out at $3.1 million in Q2 2025 and bottomed at $4000.0 in Q3 2023.
- A 5-year average of $1.2 million and a median of $678000.0 in 2022 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2023 — Current Leases slumped 99.7% — and 2024, when it soared 71300.0%.
- Neurogene's Current Leases stood at $678000.0 in 2022, then tumbled by 93.81% to $42000.0 in 2023, then climbed by 28.57% to $54000.0 in 2024, then sank by 74.07% to $14000.0 in 2025, then sank by 35.71% to $9000.0 in 2026.
- Business Quant data shows NGNE's Current Leases at $9000.0 in Q1 2026, $14000.0 in Q4 2025, and $3.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Neurogene | 17.50 Mn | 17.50 Mn | - | 9,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9,000.00 |
| Dec 31, 2025 | 14,000.00 |
| Sep 30, 2025 | 3.07 Mn |
| Jun 30, 2025 | 3.09 Mn |
| Mar 31, 2025 | 48,000.00 |
| Dec 31, 2024 | 54,000.00 |
| Sep 30, 2024 | 2.86 Mn |
| Jun 30, 2024 | 2.77 Mn |
| Mar 31, 2024 | 2.67 Mn |
| Dec 31, 2023 | 42,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 1.49 Mn |
| Mar 31, 2023 | 304,000.00 |
| Dec 31, 2022 | 678,000.00 |
| Sep 30, 2022 | 1.32 Mn |
| Jun 30, 2022 | 118,000.00 |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 1.17 Mn |
| Sep 30, 2021 | 104,000.00 |
| Jun 30, 2021 | 104,000.00 |